FDA launches new digital health adcomm to tackle incoming complexities

The FDA on Wednes­day launched a new ad­vi­so­ry com­mit­tee to re­view what will like­ly be an in­flux of new is­sues sur­round­ing nov­el health tech that’s grow­ing in­creas­ing­ly com­plex.

Like oth­er FDA ad­comms, the new Dig­i­tal Health Ad­vi­so­ry Com­mit­tee will fo­cus its at­ten­tion on these com­plex sci­en­tif­ic and tech­ni­cal is­sues. In this case, those is­sues will be re­lat­ed to dig­i­tal health tech­nolo­gies, which have his­tor­i­cal­ly ranged from un­reg­u­lat­ed mo­bile health apps to high­ly reg­u­lat­ed soft­ware that can help with clin­i­cal de­ci­sion-mak­ing.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.